MM-433593

• CAT Number: I008119
• CAS Number: 1006604-91-6
• Molecular Formula: C25H22ClN3O3
• Molecular Weight: 447.92
• Purity: ≥95%
• Synonyms: MM-433593; MM-433593; MM-433593;2-(1-(4-chlorobenzyl)-2,5-dimethyl-1H-indol-3-yl)-N-(2-methoxypyridin-4-yl)-2-oxoacetamide
• Target: Fatty Acid Amide Hydrolase (FAAH) Inhibitor
• Solubility: Soluble in DMSO
• Storage: Desiccate at RT
• IUPAC Name: 2-[1-[(4-chlorophenyl)methyl]-2,5-dimethylindol-3-yl]-N-(2-methoxypyridin-4-yl)-2-oxoacetamide
• InChI: InChI=1S/C25H22ClN3O3/c1-15-4-9-21-20(12-15)23(16(2)29(21)14-17-5-7-18(26)8-6-17)24(30)25(31)28-19-10-11-27-22(13-19)32-3/h4-13H,14H2,1-3H3,(H,27,28,31)
• InChIKey: RIKZRSJVZWKHNX-UHFFFAOYSA-N
• SMILES: CC1=CC2=C(C=C1)N(C(=C2C(=O)C(=O)NC3=CC(=NC=C3)OC)C)CC4=CC=C(C=C4)Cl

MM-433593(CAT: I008119) is a potent inhibitor of fatty acid amide hydrolase (FAAH), an enzyme responsible for degrading endocannabinoids such as anandamide. By inhibiting FAAH, MM-433593 enhances endocannabinoid signaling, providing potential therapeutic benefits in the treatment of pain, inflammation, and neurological disorders. This compound is particularly valuable in pain management and neuroinflammation research, supporting studies on the endocannabinoid system’s role in modulating pain and immune responses. MM-433593 is a critical tool for exploring FAAH inhibition as a therapeutic strategy and advancing drug discovery for conditions involving dysregulated endocannabinoid signaling.